Volatile organic compounds in ventilated critical care patients: a systematic evaluation of cofactors

BMC Pulmonary Medicine

Table 4 Main diagnosis, anaesthetics, and volatile organic compounds in the exhalome of five critical care patients

	Patient 1 59 VOCs	Patient 2 58 VOCs	Patient 3 55 VOCs	Patient 4 45 VOCs	Patient 5 44 VOCs
Diagnosis	Haemorrhagic shock, Peripartum atonic bleeding	Sepsis, Perforated sigmoid diverticulitis	Polytrauma, Brain injury	Sepsis, Mamma carcinoma	Femur fracture, Respiratory insufficiency
Sedation	Propofol and Remifentanil	Piritramide	Propofol and Remifentanil	Propofol and Remifentanil	Propofol and Remifentanil
VOCs in	P14, P30, P58, P62, P68	P13, P18, P67, P74	P69, P70, P71, P73		P61
1 patient
(n = 14)
VOCs in 2 patients (n = 9)			P54
	P45, P57		P45, P57
	P3, P6, P47, P59, P60, P63
VOCs in 3 patients (n = 7)	P5		P5	P5
		P11		P11	P11
		P38
		P65, P66	P65, P66		P65, P66
	P51, P64
VOCs in 4 patients (n = 7)	P24
	P48		P48	P48	P48
	P4, P16	P4, P16	P4, P16		P4, P16
	P17, P35, P76
VOCs in all patients (n = 36)	P1, P2, P7, P8, P9, P10, P12, P15, P19, P21, P22, P23, P25,
	P26, P27, P28, P31, P32, P33, P34, P36, P37, P39, P40, P41,
	P42, P43, P44, P46, P49, P50, P52, P53, P55, P56, P72

36 compounds are detectable in all patients, respectively. Other volatiles are merely seen in 1, 2, 3, or 4 patients

ISSN: 1471-2466